NASDAQ: IOVA

US Markets

Iovance Biotherapeutics (NASDAQ: IOVA) Stock Surges on Bullish Price Target Revisions

Edward Cooke / 22 February 2024

Iovance Biotherapeutics (NASDAQ: IOVA) stock spiked on Wednesday after receiving multiple price target upgrades post-FDA accelerated approval. Iovance Biotherapeutics (IOVA) […]

Iovance Biotherapeutics (NASDAQ: IOVA) Stock Surges on Bullish Price Target Revisions Read More »

US Markets

Iovance Biotherapeutics (NASDAQ: IOVA) Stock Soars on This Milestone Achievement

Salman Akhtar / 21 February 2024

Iovance Biotherapeutics (NASDAQ: IOVA) stock jumped after the FDA granted accelerated approval for Amtagvi (lefileucel) as a treatment for advanced

Iovance Biotherapeutics (NASDAQ: IOVA) Stock Soars on This Milestone Achievement Read More »

News, US Markets

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) Shares Fall Amidst Citigroup Inc.’s Reduced Stake

Zabih Ullah / 27 May 2023

Shares of Iovance Biotherapeutics (IOVA) experienced a decline of -1.82% following news of Citigroup Inc. reducing its holdings in the

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) Shares Fall Amidst Citigroup Inc.’s Reduced Stake Read More »

Iovance Biotherapeutics (NASDAQ: IOVA) Stock Surges on Bullish Price Target Revisions

Iovance Biotherapeutics (NASDAQ: IOVA) Stock Soars on This Milestone Achievement

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) Shares Fall Amidst Citigroup Inc.’s Reduced Stake

Company

About Us

Team

Contact Us

Categories

US Market

Business

Technology

News

Featured

Press Release

Legal

Privacy Policy

Disclaimer